Wikidata

(Q40616342)

English

Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.

scientific article published on November 2003

In more languages

Statements

title
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
14617792
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14617792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40616342&oldid=1561075028"